Resultaten visas 1 - 10 / 85
resultat / per sida
Vilka uppgifter om den beviljade bidragen finns i tjänsten?
Beviljade finansiering
Finansiär
Mottagare
Startår
Projekt information ikonTransdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy (ESTRACISE): Randomized controlled trialOrion Forskningsstiftelse srIlkka Jussila2025Projekt information ikonValidation of a novel diagnostic tool for prostate cancer based on multiplex biomarkers with AI-based spatial analysisFinlands AkademiHelsingin yliopisto2025Projekt information ikonDiscrimination between prostate cancer and benign prostatic hyperplasia using 1H-NMR metabolomics and Machine Learn-ingFinlands AkademiÅbo Akademi2025Projekt information ikonMacrophage Targets for Metastatic TreatmentEuropeiska unionenGENEVIA TECHNOLOGIES OY; FARON PHARMACEUTICALS OY; Helsingfors universitet; Tammerfors universitet2024Projekt information ikonSatunnaistettu koe kliinisesti merkittävän eturauhassyövän seulonnasta Randomised trial of screening for clinically significant prostate cancerCancerstiftelsen sr.Anssi Auvinen2024Projekt information ikonImpact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy – lipid metabolism as a novel biomarker to predict prostate cancer progression – phase 3, double-blind randomized clinical trial ESTO2/FinnProstata XV Cancerstiftelsen sr.Teemu Murtola2024Projekt information ikonTumor Microenvironment in Prostate Cancer Treatment Response and Resistance Kasvaimen mikroympäristön rooli eturauhassyövän hoitovasteessa ja -resistenssissäCancerstiftelsen sr.Matti Nykter2024Projekt information ikonTargeting drug-induced selection pressure on RNA processing routes in prostate cancer Kohdennettujen lääkehoitojen kehittäminen RNA-säätelyreiteille eturauhassyövän lääkeresistenssissäCancerstiftelsen sr.Leena Latonen2024Projekt information ikonLethal cancer-stromal interactions (LCSI) uncovered in prostate cancer: towards individualized therapeutic opportunities Eturauhassyöpäsolujen ja fibroblastien vuorovaikutuksen kartoitus: Kohti yksilöllisiä hoitojaCancerstiftelsen sr.Olli Kallioniemi2024Projekt information ikonSensitive detection of circulating tumor DNA fraction dynamics and evaluation of its clinical utility in metastatic castration-resistant prostate cancerOrion Forskningsstiftelse srSinja Julia Taavitsainen2024
Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy (ESTRACISE): Randomized controlled trial
2025
Validation of a novel diagnostic tool for prostate cancer based on multiplex biomarkers with AI-based spatial analysis
2025
Discrimination between prostate cancer and benign prostatic hyperplasia using 1H-NMR metabolomics and Machine Learn-ing
2025
Macrophage Targets for Metastatic Treatment
2024
Satunnaistettu koe kliinisesti merkittävän eturauhassyövän seulonnasta Randomised trial of screening for clinically significant prostate cancer
2024
Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy – lipid metabolism as a novel biomarker to predict prostate cancer progression – phase 3, double-blind randomized clinical trial ESTO2/FinnProstata XV
2024
Tumor Microenvironment in Prostate Cancer Treatment Response and Resistance Kasvaimen mikroympäristön rooli eturauhassyövän hoitovasteessa ja -resistenssissä
2024
Targeting drug-induced selection pressure on RNA processing routes in prostate cancer Kohdennettujen lääkehoitojen kehittäminen RNA-säätelyreiteille eturauhassyövän lääkeresistenssissä
2024
Lethal cancer-stromal interactions (LCSI) uncovered in prostate cancer: towards individualized therapeutic opportunities Eturauhassyöpäsolujen ja fibroblastien vuorovaikutuksen kartoitus: Kohti yksilöllisiä hoitoja
2024
Sensitive detection of circulating tumor DNA fraction dynamics and evaluation of its clinical utility in metastatic castration-resistant prostate cancer
2024